• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐源性卒中:嫌疑人太多,难以找到罪魁祸首?

Cryptogenic stroke: too many suspects to find a culprit?

作者信息

Ferri Claudio, Baldini Gianluca, Ferri Livia

机构信息

MeSVA Department-Chair and School of Internal Medicine, University of L'Aquila, L'Aquila, Italy.

出版信息

Eur Heart J Suppl. 2025 Apr 16;27(Suppl 3):iii93-iii97. doi: 10.1093/eurheartjsupp/suaf023. eCollection 2025 Mar.

DOI:10.1093/eurheartjsupp/suaf023
PMID:40248313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12001793/
Abstract

A cerebral stroke is a heterogeneous entity and-in the context of this heterogeneity-a cryptogenic stroke, that is, of unknown origin at the time of diagnosis, finds a worthy position. Cryptogenic strokes are ∼25% of ischaemic strokes and in hindsight, they often appear to be of obvious or highly presumptive origin. Knowledge of the causes of a cerebral stroke that are not immediately evident is, therefore, fundamental for the purposes of correct secondary and, hopefully, primary prevention. Certainly, in fact, a cryptogenic stroke may require appropriate treatment, which is similar to a stroke whose origin is immediately evident. Equally certainly, however, cryptogenic stroke can benefit from specific treatments, which the lack of diagnosis of origin is destined to nullify. Therefore, it must unfortunately be accepted that a minority of cryptogenic strokes remain without a culprit and, therefore, without a specific corrective treatment. However, the insistent deepening of the diagnostic process in 'obscure' cases must also be pursued. Only the unyielding examination of these cases, in fact, is destined to identify a covert vasculitis, Fabry disease, occult atrial fibrillation, or one of the many pathologies, often far from rare, which require a therapy as specific as it is life-saving. In this brief review, therefore, we will try to fully expand on the identifiable causes of cryptogenic stroke.

摘要

脑卒是一种异质性疾病,在这种异质性背景下,隐源性卒中(即在诊断时病因不明)占有重要地位。隐源性卒中约占缺血性卒中的25%,事后看来,其病因往往看似明显或高度可疑。因此,了解那些并非即刻明了的脑卒病因,对于正确的二级预防乃至有望实现的一级预防至关重要。事实上,隐源性卒中确实可能需要与病因明确的卒中相似的适当治疗。然而同样确定的是,隐源性卒中可受益于特定治疗,而病因不明注定会使这些治疗无法发挥作用。因此,不幸的是,必须承认少数隐源性卒中仍找不到病因,因而没有特定的纠正性治疗方法。然而,对于“不明原因”病例,仍必须持续深入诊断过程。事实上,只有对这些病例进行坚持不懈的检查,才有可能识别出隐匿性血管炎、法布里病、隐匿性心房颤动或众多虽不罕见但需要特定且能挽救生命治疗的疾病之一。因此,在这篇简短的综述中,我们将尽力全面阐述隐源性卒中的可识别病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3088/12001793/d2f624e9afbf/suaf023f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3088/12001793/01bdef0d9df1/suaf023f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3088/12001793/d2f624e9afbf/suaf023f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3088/12001793/01bdef0d9df1/suaf023f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3088/12001793/d2f624e9afbf/suaf023f2.jpg

相似文献

1
Cryptogenic stroke: too many suspects to find a culprit?隐源性卒中:嫌疑人太多,难以找到罪魁祸首?
Eur Heart J Suppl. 2025 Apr 16;27(Suppl 3):iii93-iii97. doi: 10.1093/eurheartjsupp/suaf023. eCollection 2025 Mar.
2
Cryptogenic stroke - How to make sense of a non-diagnostic entity.不明原因脑卒中——如何理解非诊断实体。
Maturitas. 2019 Apr;122:44-50. doi: 10.1016/j.maturitas.2019.01.004. Epub 2019 Jan 11.
3
Cryptogenic Stroke: Diagnostic Workup and Management.隐源性卒中:诊断检查与管理
Curr Treat Options Cardiovasc Med. 2019 Dec 3;21(11):77. doi: 10.1007/s11936-019-0786-4.
4
[Cryptogenic stroke management : where are we ?].[隐源性卒中的管理:我们目前处于什么阶段?]
Ann Cardiol Angeiol (Paris). 2021 Dec;70(6):373-379. doi: 10.1016/j.ancard.2021.10.006. Epub 2021 Nov 4.
5
Diagnosis, prognosis, and management of cryptogenic stroke.隐源性卒中的诊断、预后及管理
F1000Res. 2016 Feb 12;5. doi: 10.12688/f1000research.7384.1. eCollection 2016.
6
Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review.不明来源栓塞性卒中且无确切房颤病史患者的二级卒中预防:临床综述。
J Am Heart Assoc. 2021 Jul 6;10(13):e021045. doi: 10.1161/JAHA.121.021045. Epub 2021 Jul 2.
7
From cryptogenic to ESUS: Toward precision medicine?从隐源性到 ESUS:走向精准医学?
Rev Neurol (Paris). 2022 Nov;178(9):939-952. doi: 10.1016/j.neurol.2022.01.016. Epub 2022 May 18.
8
Current perspectives on the clinical management of cryptogenic stroke.关于隐源性卒中的临床管理的当前观点。
Expert Rev Neurother. 2023 Mar;23(3):213-226. doi: 10.1080/14737175.2023.2192403. Epub 2023 Mar 19.
9
Recurrent Multifocal Embolic Strokes in a 50-Year-Old Male: Unmasking Occult Squamous Cell Carcinoma.一名50岁男性复发性多灶性栓塞性中风:隐匿性鳞状细胞癌的揭示
Cureus. 2023 Sep 12;15(9):e45091. doi: 10.7759/cureus.45091. eCollection 2023 Sep.
10
[Stroke as the first manifestation of atrial fibrillation].[心房颤动的首发表现为中风]
Wiad Lek. 2018;71(9):1829-1834.

本文引用的文献

1
Recent Development of Biodegradable Occlusion Devices for Intra-Atrial Shunts.用于心房分流的可生物降解封堵装置的最新进展
Rev Cardiovasc Med. 2024 May 8;25(5):159. doi: 10.31083/j.rcm2505159. eCollection 2024 May.
2
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder.植入式环路记录器在不明来源栓塞性卒中患者中检测心房颤动的预测因素。
Front Cardiovasc Med. 2024 Mar 4;11:1369914. doi: 10.3389/fcvm.2024.1369914. eCollection 2024.
3
Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall.
免疫检查点抑制剂与动脉粥样硬化性心血管疾病风险之间的关联:墙上的又一块砖。
Int J Mol Sci. 2024 Feb 21;25(5):2502. doi: 10.3390/ijms25052502.
4
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study.原发性系统性血管炎的卒中频率、相关因素及临床特征:一项多中心观察性研究。
J Neurol. 2024 Jun;271(6):3309-3320. doi: 10.1007/s00415-024-12251-1. Epub 2024 Mar 12.
5
Treatment and Outcomes of Cervical Artery Dissection in Adults: A Scientific Statement From the American Heart Association.成人颈内动脉夹层的治疗和结局:美国心脏协会的科学声明。
Stroke. 2024 Mar;55(3):e91-e106. doi: 10.1161/STR.0000000000000457. Epub 2024 Feb 1.
6
Patent Foramen Ovale Management for Secondary Stroke Prevention: State-of-the-Art Appraisal of Current Evidence.卵圆孔未闭管理用于二级卒中预防:当前证据的最新评价。
Stroke. 2024 Jan;55(1):236-247. doi: 10.1161/STROKEAHA.123.040546. Epub 2023 Nov 21.
7
Aortic Arch Plaques and the Long-Term Risk of Stroke and Cardiovascular Events in the Statin Era.他汀时代主动脉弓斑块与卒中及心血管事件的长期风险
Stroke. 2024 Jan;55(1):69-77. doi: 10.1161/STROKEAHA.123.044546. Epub 2023 Dec 8.
8
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association.《2021年卒中与短暂性脑缺血发作患者卒中预防指南:美国心脏协会/美国卒中协会指南》
Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24.
9
Cerebrovascular manifestations of tumors of the heart.心脏肿瘤的脑血管表现。
Handb Clin Neurol. 2021;177:275-282. doi: 10.1016/B978-0-12-819814-8.00016-0.
10
Race and Ethnic Disparities in Stroke Incidence in the Northern Manhattan Study.北方曼哈顿研究中的中风发病率的种族和民族差异。
Stroke. 2020 Apr;51(4):1064-1069. doi: 10.1161/STROKEAHA.119.028806. Epub 2020 Feb 12.